Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Esteban-Burgos

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Cell|February 4, 2018
c-RAF Ablation Induces Regression of Advanced Kras/Trp53 Mutant Lung Adenocarcinomas by a Mechanism Independent of MAPK SignalingManuel Sanclemente, Sarah Francoz, Laura Esteban-Burgos, et al.
Nature|August 8, 2017
A Braf kinase-inactive mutant induces lung adenocarcinomaPatricia Nieto, Chiara Ambrogio, Laura Esteban-Burgos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 16, 2014
Chronic lymphocytic leukemia: a paradigm of innate immune cross-toleranceTeresa Jurado-Camino, Raúl Córdoba, Laura Esteban-Burgos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 17, 2014
NFκB2/p100 is a key factor for endotoxin tolerance in human monocytes: a demonstration using primary human monocytes from patients with sepsisCarolina Cubillos-Zapata, Enrique Hernández-Jiménez, Víctor Toledano, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2020
Tumor regression and resistance mechanisms upon CDK4 and RAF1 inactivation in KRAS/P53 mutant lung adenocarcinomasLaura Esteban-Burgos, Haiyun Wang, Patricia Nieto, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 2024
Type I interferon signaling pathway enhances immune-checkpoint inhibition in KRAS mutant lung tumorsFernando Fernández-García, Ana Fernández-Rodríguez, Coral Fustero-Torre, et al.
Plos One|May 7, 2014
Mitochondrial DAMPs induce endotoxin tolerance in human monocytes: an observation in patients with myocardial infarctionIrene Fernández-Ruiz, Francisco Arnalich, Carolina Cubillos-Zapata, et al.
Cancer Cell|April 13, 2019
Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAFMaría Teresa Blasco, Carolina Navas, Guillermo Martín-Serrano, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Cell|February 4, 2018
c-RAF Ablation Induces Regression of Advanced Kras/Trp53 Mutant Lung Adenocarcinomas by a Mechanism Independent of MAPK SignalingManuel Sanclemente, Sarah Francoz, Laura Esteban-Burgos, et al.
Nature|August 8, 2017
A Braf kinase-inactive mutant induces lung adenocarcinomaPatricia Nieto, Chiara Ambrogio, Laura Esteban-Burgos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 16, 2014
Chronic lymphocytic leukemia: a paradigm of innate immune cross-toleranceTeresa Jurado-Camino, Raúl Córdoba, Laura Esteban-Burgos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 17, 2014
NFκB2/p100 is a key factor for endotoxin tolerance in human monocytes: a demonstration using primary human monocytes from patients with sepsisCarolina Cubillos-Zapata, Enrique Hernández-Jiménez, Víctor Toledano, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2020
Tumor regression and resistance mechanisms upon CDK4 and RAF1 inactivation in KRAS/P53 mutant lung adenocarcinomasLaura Esteban-Burgos, Haiyun Wang, Patricia Nieto, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 2024
Type I interferon signaling pathway enhances immune-checkpoint inhibition in KRAS mutant lung tumorsFernando Fernández-García, Ana Fernández-Rodríguez, Coral Fustero-Torre, et al.
Plos One|May 7, 2014
Mitochondrial DAMPs induce endotoxin tolerance in human monocytes: an observation in patients with myocardial infarctionIrene Fernández-Ruiz, Francisco Arnalich, Carolina Cubillos-Zapata, et al.
Cancer Cell|April 13, 2019
Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAFMaría Teresa Blasco, Carolina Navas, Guillermo Martín-Serrano, et al.
Pageof 1